Protagonist Therapeutics (PTGX) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.6
0.26
1.12
1.98

Details

Expected EPS
-0.20346
Actual EPS
-0.19
Surprise EPS
0.01
Surprise Percent
+6.62%

Description

⁨Protagonist Therapeutics⁩ (⁦PTGX⁩) has reported earnings of ⁦-0.19⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts